These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37876338)

  • 1. Systemic reaction to polycaprolactone-based dermal filler: A case report.
    Pacetti L; Cavaliere S; Schettini N; Melloni L; Borghi A
    J Cosmet Dermatol; 2024 Mar; 23(3):1087-1088. PubMed ID: 37876338
    [No Abstract]   [Full Text] [Related]  

  • 2. Granuloma as a complication of polycaprolactone-based dermal filler injection: ultrasound and histopathology studies.
    Skrzypek E; Górnicka B; Skrzypek DM; Krzysztof MR
    J Cosmet Laser Ther; 2019; 21(2):65-68. PubMed ID: 29757038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filler migration to the forehead due to multiple filler injections in a patient addicted to cosmetic fillers.
    Lin CH; Chiang CP; Wu BY; Gao HW
    J Cosmet Laser Ther; 2017 Apr; 19(2):124-126. PubMed ID: 27813656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of rheological properties and preclinical data of porous polycaprolactone microsphere dermal fillers.
    Kim JS; In CH; Park NJ; Kim BJ; Yoon HS
    J Cosmet Dermatol; 2020 Mar; 19(3):596-604. PubMed ID: 31347766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-Onset Filler-Induced Granuloma After Polycaprolactone-Based Filler Treated With High-Intensity Focused Ultrasound and Quantum Molecular Resonance Technology.
    Hong JK; Sun B; Shin SH; Kim BJ
    Dermatol Surg; 2022 Jun; 48(6):693-694. PubMed ID: 35363638
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds.
    Galadari H; van Abel D; Al Nuami K; Al Faresi F; Galadari I
    J Cosmet Dermatol; 2015 Mar; 14(1):27-32. PubMed ID: 25564797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of novel particle-free polycaprolactone fillers for safety, degradation, and neocollagenesis in a rat model.
    Hong JY; Kim JH; Kwon TR; Hong JK; Li K; Kim BJ
    Dermatol Ther; 2021 Mar; 34(2):e14770. PubMed ID: 33421287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Dermal Fillers in Patients With Connective Tissue Disease: A Review.
    Gonzalez CD; Pamatmat JJ; Goff HW
    Dermatol Surg; 2021 Mar; 47(3):360-364. PubMed ID: 34328288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Foreign Body Granulomatosis 11 Years After Injection of a Cosmetic Dermal Filler.
    Teixeira-Lopes F; Dias A; Luís R; Ferreira L
    Arch Bronconeumol (Engl Ed); 2018 Dec; 54(12):632-633. PubMed ID: 29789174
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypersensitivity reaction to RHA filler.
    Ross CL; Heitmiller K; Saedi N
    J Cosmet Dermatol; 2022 Jan; 21(1):412-413. PubMed ID: 34921498
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrasound Morphology of Polycaprolactone Filler.
    Wortsman X; Quezada N
    J Ultrasound Med; 2017 Dec; 36(12):2611-2615. PubMed ID: 28703420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycaprolactone-based dermal filler complications: A retrospective study of 1111 treatments.
    Lin SL; Christen MO
    J Cosmet Dermatol; 2020 Aug; 19(8):1907-1914. PubMed ID: 32485052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 infection-associated hypersensitivity reaction to dermal filler-A case report and review of the histologic features.
    Liu L; Ledinh W
    J Cosmet Dermatol; 2022 Sep; 21(9):3673-3674. PubMed ID: 35751425
    [No Abstract]   [Full Text] [Related]  

  • 14. Ophthalmoplegia as a complication of cosmetic facial filler injection.
    Kim A; Kim SH; Kim HJ; Yang HK; Hwang JM; Kim JS
    Acta Ophthalmol; 2016 Aug; 94(5):e377-9. PubMed ID: 26407823
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and Long-Term Efficacy of Forehead Contouring With a Polycaprolactone-Based Dermal Filler.
    Bae B; Lee G; Oh S; Hong K
    Dermatol Surg; 2016 Nov; 42(11):1256-1260. PubMed ID: 27662054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating Filler Related Visual Loss.
    Steinsapir KD
    Dermatol Surg; 2016 Apr; 42(4):552-4. PubMed ID: 26981719
    [No Abstract]   [Full Text] [Related]  

  • 17. European Multicenter Prospective Study Evaluating Long-Term Safety and Efficacy of the Polycaprolactone-Based Dermal Filler in Nasolabial Fold Correction.
    Moers-Carpi M; Christen MO; Delmar H; Brun P; Bodokh I; Kestemont P
    Dermatol Surg; 2021 Jul; 47(7):960-965. PubMed ID: 33731572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed hypersensitivity reaction to hyaluronic acid dermal filler post-COVID-19 viral infection.
    Shome D; Doshi K; Vadera S; Kapoor R
    J Cosmet Dermatol; 2021 May; 20(5):1549-1550. PubMed ID: 33682241
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective analysis of the MAUDE database on dermal filler complications from 2014-2020.
    Xiong M; Chen C; Sereda Y; Garibyan L; Avram M; Lee KC
    J Am Acad Dermatol; 2022 Nov; 87(5):1158-1160. PubMed ID: 35202776
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosacea-like acute reaction after hyaluronic acid dermal filler.
    Valenti M; Guanziroli E; Mancini LL; Costanzo A
    Ital J Dermatol Venerol; 2021 Dec; 156(Suppl. 1 to No. 6):76-77. PubMed ID: 31804049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.